Luigi Manenti

Luigi Manenti is a prominent figure in translational clinical oncology and pipeline strategy, known for his international experience and remarkable achievements in leading innovative clinical trials to enhance patient outcomes and advance the understanding of cancer biology.

Having obtained his Doctor of Medicine (MD) degree in Medicine from Università di Pavia, Luigi's educational background has laid a solid foundation for his illustrious career.

With an impressive career trajectory, Luigi has held key positions in various prestigious organizations. He currently serves as the CMO at HiFiBiO Therapeutics, where he continues to drive advancements in the field.

Prior to his role as CMO, Luigi Manenti was the Senior Vice President (Head of Clinical Development) at HiFiBiO Therapeutics, showcasing his expertise in clinical leadership and strategic decision-making.

Luigi's tenure at Novartis Oncology included serving as the Team Leader for Solid Tumors, focusing on global pipeline strategy, as well as holding roles such as Executive Clinical Program Leader and Senior Clinical Program Leader at Novartis Institutes for BioMedical Research (NIBR).

His vast experience also extends to his time at Roche Pharmaceuticals, where he contributed as the Site Head of Translational Medicine, Translational Medicine Leader (TML), and Clinical Scientist, demonstrating his versatility and wide-ranging skills in the pharmaceutical industry.

Early in his career, Luigi gained valuable experience as a Clinical Manager Assistant at MolMed and as a Student/Graduate Student Researcher at Istituto Mario Negri.